Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

GLAUKOS CORPORATION

Filed by GLAUKOS CORPORATION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 10, 2026
Income
Not reported
Expenses
$280,000.00
Filing UUID
55ab303c-980b-4d65-9a4e-b8e5c3c205a2
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

H.R. 3514/ S. 1816 Improving Seniors Timely Access to Care Act of 2025 H.R. 2527 Early Detection of Vision Impairments for Children Act of 2025

Literal federal measure citations: H.R. 3514, S. 1816, H.R. 2527

MED · Medical/Disease Research/Clinical Labs

Legislation regarding FDA regulation of combination products H.R. 1261/ S. 3302 Mikaela Naylon Give Kids a Chance Act Bill

Literal federal measure citations: H.R. 1261, S. 3302

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.